Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis Sells 238 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 238 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $477.50, for a total transaction of $113,645.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,629,115. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Robert Desantis also recently made the following trade(s):

• On Thursday, August 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48.
• On Monday, August 26th, Robert Desantis sold 396 shares of Intuitive Surgical stock. The stock was sold at an average price of $486.88, for a total value of $192,804.48.
• On Monday, August 12th, Robert Desantis sold 240 shares of Intuitive Surgical stock. The shares were sold at an average price of $464.76, for a total value of $111,542.40.
• On Friday, July 26th, Robert Desantis sold 1,413 shares of Intuitive Surgical stock. The stock was sold at an average price of $438.60, for a total value of $619,741.80.
• On Monday, July 29th, Robert Desantis sold 376 shares of Intuitive Surgical stock. The stock was sold at an average price of $446.60, for a total value of $167,921.60.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $484.24 on Wednesday. The firm has a 50-day moving average of $460.51 and a 200-day moving average of $419.84. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $493.97. The company has a market cap of $171.76 billion, a P/E ratio of 87.41, a P/E/G ratio of 5.20 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. During the same quarter last year, the business posted $1.18 EPS. The company’s revenue for the quarter was up 14.5% on a year-over-year basis. As a group, research analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Institutional Trading of Intuitive Surgical

Hedge funds have recently bought and sold shares of the business. One Wealth Management Investment & Advisory Services LLC increased its position in shares of Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after purchasing an additional 23 shares during the last quarter. Indiana Trust & Investment Management CO grew its position in Intuitive Surgical by 5.3% during the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 25 shares during the period. Hoxton Planning & Management LLC increased its holdings in Intuitive Surgical by 4.9% during the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after buying an additional 25 shares during the last quarter. First Affirmative Financial Network raised its position in Intuitive Surgical by 2.7% in the second quarter. First Affirmative Financial Network now owns 996 shares of the medical equipment provider’s stock worth $443,000 after acquiring an additional 26 shares during the period. Finally, Moors & Cabot Inc. boosted its stake in Intuitive Surgical by 2.3% in the second quarter. Moors & Cabot Inc. now owns 1,159 shares of the medical equipment provider’s stock valued at $516,000 after acquiring an additional 26 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. BTIG Research boosted their target price on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. Stifel Nicolaus raised their target price on Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Evercore ISI dropped their price target on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research note on Friday, July 19th. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Robert W. Baird upped their target price on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $446.45.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.